PTC299
目录号: A18935
VEGFA inhibitor
PTC299 是一种有效的、可口服的 VEGFA 抑制剂,其靶向 二氢乳酸脱氢酶 (DHODH),导致白血病(包括急性髓细胞性白血病)中的细胞生长抑制和分化,将 DHODH 调控与应激诱导的 VEGFA 和 血管生成 相联系。
Discription | PTC299 is a potent, orally bioavailable VEGFA inhibitor, targets dihydroorotate dehydrogenase (DHODH), resulting in cell growth inhibition and differentiation in leukemias, including acute myeloid leukemia, linking DHODH regulation and stress-induced VEGFA and angiogenesis. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A18935 |
---|---|
分子式 | C25H20Cl2N2O3 |
分子量 | 467.34 |
CAS号 | 1256565-36-2 |
SMILES | O=C(N([C@H]1C2=CC=C(OC)C=C2)CCC3=C1NC4=C3C=C(Cl)C=C4)OC5=CC=C(Cl)C=C5 |
其他名称 | PTC-299, PTC 299 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2